Chronic Lymphocytic Leukemia

3:33

Jan Burger, M.D., Ph.D., and Susan O'Brien, M.D., of Leukemia at MD Anderson Cancer Center explain the impact of the targeted therapy drug ibrutinib verses chemotherapy treatment for CLL (chronic lymphocytic leukemia) using laymen's terms.

2:09
0:00

BMM-Oncology is an, independent, on-line, research, news and education channel designed to communicate the latest in clinical research and development, news, trending topics, current opinion, congress updates, expert interviews and debates, and other vital information to the global oncology and haematology communities. Owned and published by Biopharma Medical Multimedia, healthcare professional educator and publisher of the European Journal of Clinical and Medical Oncology ad EJCMO.TV to fill the urgent need for rapid communication of critical information in the form of video, audio article content. BMM-Oncology is editorially independent of any commercial interests. Our Mission is to keep the oncology community up to date with the latest research and clinical advances with the aim of constantly improving clinical outcome.

0:00

BMM-Oncology is an, independent, on-line, research, news and education channel designed to communicate the latest in clinical research and development, news, trending topics, current opinion, congress updates, expert interviews and debates, and other vital information to the global oncology and haematology communities. Owned and published by Biopharma Medical Multimedia, healthcare professional educator and publisher of the European Journal of Clinical and Medical Oncology ad EJCMO.TV to fill the urgent need for rapid communication of critical information in the form of video, audio article content. BMM-Oncology is editorially independent of any commercial interests. Our Mission is to keep the oncology community up to date with the latest research and clinical advances with the aim of constantly improving clinical outcome.

6:14

Chronic lymphocytic leukemia, or CLL, is one of the most common types of blood cancers, with about 16,000 patients in the United States each year. In this video, Mayo Clinic hematologist Dr. Wei Ding discusses new treatments being developed to help patients fighting CLL.

7:37

Mayo Clinic Dr. Tim Call describes Chronic Lymphocytic Leukemia (CLL), its diagnosis, and treatment options for patients with CLL.

7:36

Dr. Steven Rosen, Director of the Lurie Cancer Center in Chicago, shares his perspective on the latest news from the American Society of Hematology's 2011 annual meeting, focused around major advances in Chronic Lymphocytic Leukemia (CLL). A new, non-chemotherapy approach may provide a better tolerated approach to treating the disease, especially for older patients and those with genetic variations that do not respond to the current standard of care.

Advertisement